Cure Pharmaceutical
Cure Pharmaceutical researches, innovates, and manufactures unique orodispersible dosage forms to enhance patient compliance and accessibility, with a focus on improving medication absorption and release.
Services
Cure Pharmaceutical specializes in the research, innovation, and manufacturing of orodispersible dosage forms. These unique, patented solutions are designed to enhance patient compliance and accessibility. Their services include the creation of innovative process technology platforms that enhance the effectiveness and utility of existing molecules. By improving medication absorption and release, Cure Pharmaceutical's offerings avoid first-pass metabolism, providing convenience and ease of use while typically reducing the amount of active drugs needed for improved safety profiles.
Products
Cure Pharmaceutical has developed several significant products, notably the CUREfilm® technology. This unique dosage form offers both sublingual and buccal delivery options, absorbing rapidly and directly into the bloodstream. CUREfilm® is designed for pharmaceuticals, vaccines, and nutraceuticals, making it particularly useful for rural and underserved markets. Notable applications include CUREfilm® Blue for erectile dysfunction, an oral thin film insulin for diabetes, and an oral hepatitis B vaccine. CUREfilm® products eliminate the need for injections and are stable at room temperature, which removes the necessity for refrigeration.
Manufacturing Facility
Cure Pharmaceutical operates a 25,000 square foot manufacturing facility that is FDA and cGMP certified. This facility is equipped to handle the development and production of their innovative dosage forms. The certification ensures adherence to stringent quality and safety standards, vital for producing pharmaceuticals, vaccines, and nutraceuticals. This facility is integral to the company’s ability to manufacture its patented CUREfilm® technology, ensuring high-quality and reliable products.
Patents
Cure Pharmaceutical holds a robust intellectual property portfolio with 43 issued and pending US patents. These patents cover their innovative dosage forms and process technology platforms. This extensive patent portfolio highlights the company's commitment to pioneering advancements in drug delivery systems and ensuring the protection of their proprietary technologies.
Headquarters and Locations
Cure Pharmaceutical is headquartered in Oxnard, California. The company also has additional locations in Sarasota, Florida, and Mexico City, Mexico. These strategic locations enable the company to efficiently manage operations and serve various markets across North America.